Michigan Medicine, formerly the University of Michigan Health System, is the wholly owned academic medical center of the University of Michigan, in Ann Arbor.

During the past decade, University of Michigan Medical Center conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 59 clinical trials were completed, i.e. on average, 118% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 24 clinical trials were completed. i.e. 141.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Michigan Medical Center" #1 sponsor was "Medical College of Wisconsin" with 14 trials, followed by "University of Michigan" with 14 trials sponsored, "National Heart, Lung, and Blood Institute (NHLBI)" with 6 trials sponsored, "Massachusetts General Hospital" with 5 trials sponsored and "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 5 trials sponsored. Other sponsors include 94 different institutions and companies that sponsored additional 83 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Michigan Medical Center" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 27 trials as a collaborator, "National Cancer Institute (NCI)" with 23 trials as a collaborator, "Blood and Marrow Transplant Clinical Trials Network" with 20 trials as a collaborator, "National Marrow Donor Program" with 16 trials as a collaborator and "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 6 trials as a collaborator. Other collaborators include 99 different institutions and companies that were collaborators in the rest 94 trials.

According to Clinical.Site data, the most researched conditions in "University of Michigan Medical Center" are "Acute Respiratory Distress Syndrome" (4 trials), "Leukemia" (4 trials), "Multiple Myeloma" (4 trials), "Acute Liver Failure" (3 trials) and "Amyotrophic Lateral Sclerosis" (3 trials). Many other conditions were trialed in "University of Michigan Medical Center" in a lesser frequency.

Most popular intervention types in "University of Michigan Medical Center" are "Drug" (84 trials), "Biological" (18 trials), "Procedure" (15 trials), "Device" (14 trials) and "Other" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Mycophenolate Mofetil" (4 trials), "Tacrolimus" (4 trials), "Lenalidomide" (3 trials) and "AMX0035" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Michigan Medical Center" are 136 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 23 active trials in "University of Michigan Medical Center". 1 are not yet recruiting, 11 are recruiting, 9 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 100 completed trials in University of Michigan Medical Center, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in University of Michigan Medical Center, 11 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 59 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 15 trials that are defined as “Not Applicable".

University of Michigan Medical Center has several departments that took part in Clinical trials: "East Ann Arbor Health and Geriatrics Center" - 5 trials, "Retina Vitrous Center" - 4 trials, "University of Michigan - Infectious Disease Clinic at Taubman Center" - 3 trials, "University of Michigan Hemophilia and Coagulation Disorders" - 2 trials, "University of Michigan Health System Emergency Department" - 2 trials, "University of Michigan Comprehensive Cancer Center Onc Dept" - 2 trials